Introduction
Despite claims of superior safety and effectiveness compared to the older anticoagulant warfarin, there is thin supporting evidence that Eliquis is safer or more effective than warfarin. Unlike warfarin, Eliquis does not have an antidote that allows doctors to stop bleeding complications, nor does it require regular blood monitoring that can help prevent dangerous bleeding events. The Eliquis approval process has also come under scrutiny for reported irregularities at a clinical trial site.
History of the Case
The lawsuits accuse the company of selling a dangerous product. They also claim the company used deceptive advertising and hid the risk of complications.
Currently, there are no Mirena class action lawsuits in the U.S., but there are three main groups of individual lawsuits, two in New York and one in New Jersey. So far, Bayer has only offered to settle perforation lawsuits.
More than 130 lawsuits have been filed against Bristol-Myers Squibb and Pfizer over alleged injuries and deaths caused by Eliquis. Plaintiffs in Eliquis lawsuits make a number of accusations against the drugmakers, including the following:
- Not providing adequate warnings about Eliquis’ lack of a bleeding reversal agent
- Overstating the safety of Eliquis while downplaying its risks
- Failing to conduct complete and proper testing of Eliquis
- Bringing to market a drug with unreasonable, dangerous side effects
- Breaching a drug maker’s duty to bring to market reasonably safe products
- Negligently advertising and recommending Eliquis without sufficient knowledge of its dangers
- Concealing product safety information from the public
- Prioritizing profits over patient safety
- Committing fraud during Eliquis testing
- Causing patient injuries and deaths as a result of these acts and omissions
Injuries Related to Product
Eliquis may cause internal bleeding that is serious, irreversible, and potentially fatal. Eliquis bleeding risks include:
- Gastrointestinal bleeding
- Kidney bleeding
- Rectal bleeding
- Eye bleeding
- Spinal bleeding
- Cerebral hemorrhage
- Stroke
- Death
Frequently Asked Questions
Is there an Eliquis class action lawsuit?
Yes, Eliquis lawsuits have been filed individually and as part of class action proceedings in various jurisdictions. Cases are being monitored across the country, and the litigation landscape continues to evolve. An attorney can advise you on whether an individual lawsuit or participation in a class action is more appropriate for your specific situation.
What are the serious side effects associated with Eliquis?
The most serious reported side effects of Eliquis include uncontrolled internal and external bleeding, gastrointestinal hemorrhage, intracranial bleeding (brain bleeds), spinal epidural hematoma, and stroke. These events can be life-threatening and may occur without adequate warning.
Who is eligible to file an Eliquis lawsuit?
You may be eligible to file an Eliquis lawsuit if you or a family member took Eliquis and subsequently experienced a serious bleeding event, stroke, or other severe complication. The estates of patients who died as a result of Eliquis-related injuries may also be able to pursue a wrongful death claim.
What compensation may be available in an Eliquis lawsuit?
Compensation may include costs for emergency and ongoing medical treatment, rehabilitation expenses, lost income, and damages for pain and suffering. The value of any individual claim depends on the nature and severity of the injuries involved.
What is the statute of limitations for filing an Eliquis lawsuit?
Statutes of limitations for drug injury claims vary by state but are typically two to three years from the date you knew or should have known your injury was linked to Eliquis. Because these deadlines can be complex in drug litigation, speaking with a lawyer promptly is critical to preserving your right to file.